# Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis

> **NCT02839356** · PHASE4 · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 670 (estimated)

## Conditions studied

- Post-ERCP Acute Pancreatitis

## Interventions

- **DRUG:** epinephrine
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT02839356
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 670 (ESTIMATED)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839356, "Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02839356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*